Thankyou, Elsie. I couldn't ask for more. You know, I was just sitting here reading some of the many notes I have taken over the last couple of years, and one just stood out, and as I read it again it just really rubbed me the wrong way. In Seeking Alpha there is a Cyberonics Earnings Call Transcript from Feb. 19, 2009. On July 15, 2005, when Cyberonics was granted their Depression Approval, it came with something referred to as 'Conditions of Approval'. What this means is that they can go ahead and market their device for the treatment of depression legally as of July 15, 2005, but the company had to be actively trying to complete these certain 'conditions' that the FDA gave them to really insure them that this device DID work and that it was safe for consumers. So, on that date they were told to do a 450-patient post-marketing dosing study and a 1,000 patient 5-year out-come registry. In this Earnings Call Transcript, which you also can pull up on your computer and read the whole thing, Daniel Moore is talking about the request that the company had submitted to the FDA to change the enrollment of the Dosing Study that they were instructed to do as part of these Conditions from 460 patients down to 330, and said that they were in discussions with the FDA right now about doing that. Then Anthony Petrone [Mason-Group] asks him what the savings to the company would be and Gregory H. Browne tells him that over a 12-month period it would save them about 3 to 3.5 million dollars in terms of implant and follow-up costs, and he felt that that would be very significent and is just waiting on what the FDA says. Okay, now, this is the problem I'm having with all this. Why are they discussing this almost 4 years AFTER these conditions were given? If this was something that this company did not feel was feesible, then that request should have been made when they were given the conditions, not almost four years later, after it's already been implanted in thousands and thousands of trusting people. Did the FDA really have a choice BUT to accept that proposal? If they had said no, would Cyberonics have turned around and just yanked all the devices out of everyone who got it for depression and said, oh well? If this was something they KNEW they had to do, why didn't they make that their first priority? It seems this company was more worried about expanding their business and seeking new applications for approval then they were to do these mandated clinical trials just to make sure the device wasn't going to kill a bunch of people or disable a bunch more...Oh, wait a minute. Isn't that exactly what this device IS doing?